Ilana Frishman

Ilana Frishman currently serves as the Senior Director of Drug Safety & Pharmacovigilance at Compugen since September 2023. Previously, Ilana held the position of Safety Director at Pluri from January 2021 to August 2023, where oversight of Pharmacovigilance and drug safety was provided, leading to the completion of multiple Clinical Study Reports and Development Safety Update Reports. Ilana's extensive experience at Teva Pharmaceuticals spanned from July 2006 to December 2020, including roles such as Branded Products Safety & Global Pharmacoepidemiology Team Leader, where a team of safety physicians and scientists was managed, and Team Leader for Biosimilar & Biologic products. Ilana's academic background includes an M.Sc. in Epidemiology from Tel Aviv University and a B.Pharm in Pharmacy from Ben-Gurion University of the Negev.